A report on international biosafety protocol

Agencies involved in producing policies surrounding biosafety within a hospital, pharmacy or clinical research laboratory include: Risks associated with LMOs or products thereof should be considered in the context of risks posed by the non-modified recipients or parental organisms in the likely potential receiving environment.

Ingestion risks when handling specimens, smears and cultures Risks of percutaneous exposures when using syringes and needles Bites and scratches when handling animals Handling of blood and other potentially hazardous pathological materials Decontamination and disposal of infectious material.

The Cartagena Protocol on Biosafety

Signatures and Ratifications, at http: A Party of import may, at any time, in light of new scientific information, review and change a decision. Exporters enjoy economic gains, as well as indirect benefits such as growth in the agricultural and ancillary industries.

Five-year renewals Institutional Biosafety Committee protocols are approved for five years. Synthetic vaccines are now being produced in the lab.

Although it allows the use of the precautionary principle in decision-making, the protocol also says that a nation's use of precaution must be consistent with its other trade obligations.

These have caused a lot of excitement in the pharmaceutical industry as they will be cheaper to produce, allow quicker production, as well enhance the knowledge of virology and immunology.

M [hereinafter Biosafety Protocol]. Convention on Biological Diversity, June 5,31 I.

National Reports on Implementation of the Cartagena Protocol on Biosafety

Sometimes biohazard management plans are limited only to workers in transportation specific job titles. Biosafety is becoming also a global concern and require multilevel resources and international collaboration to monitor, prevent and correct accidents from unintended and malicious release and also to prevent that bioterrorists get their hands-on biologics sample to create biologic weapons of mass destruction.

The article suggests that a possible problem with the plan is that some commodities, such as corn, that are intended as food or feed can also end up being used as seed for growing crops. In the United States, the primary methods for treatment and disposal of biohazard, medical and sharps waste may include: At its conclusion, the Working Group submitted a draft text of the Protocol, as well as the outstanding concerns of the Parties, for consideration by Conference of the Parties at its first extraordinary meeting, convened for the purpose of adopting a protocol on biosafety to the Convention on Biological Diversity.

Cartagena Protocol on Biosafety

Sometimes biohazard management plans are limited only to workers in transportation specific job titles. The Protocol specifies requirements on identification by setting out what information must be provided in documentation that should accompany transboundary shipments of LMOs.

Biosafety level Biosafety, in medicine and health care settings, specifically refers to proper handling of organs or tissues from biological origin, or genetic therapy products, viruses with respect to the environment, [6] to ensure the safety of health care workers, researchers, lab staff, patients, and the general public.

It does not cover: The details of these requirements vary according to the intended use of the LMOs, and, in the case of LMOs for food, feed or for processing, they should be further addressed by the governing body of the Protocol.

Medical Waste Tracking Act Medical waste management was identified as an issue in the s; with the Medical Waste Tracking Act of [28] becoming the new standard in biohazard waste disposal. In either case, the importing country must decide whether to allow the import, with or without conditions or deny it within days.

Scientists estimate that within the next few decades, organism design will be sophisticated enough to accomplish tasks such as creating biofuels and lowering the levels of harmful substances in the atmosphere.

Murphy, Biotechnology and International Law, 42 Harv. In short, it seeks to protect biodiversity from the potential risks of living modified organisms LMOs resulting from modern biotechnology.

The first task of the Bureau was to develop a work plan for the ICCP which was submitted, to and endorsed by, the fifth meeting of the Conference of the Parties in May They also argue that the development of these organisms will simply shift the consumption of petroleum to the utilization of biomass in order to create energy.

In addition to the CDC, the Environmental Protection Agency has some of the most accessible information on ecological impacts of biohazards, how to handle spills, reporting guidelines and proper disposal of agents dangerous to the environment.

The article can be viewed online at the link below. Common LMOs include agricultural crops that have been genetically modified for greater productivity or for resistance to pests or diseases.

Effective treatment and preventive measures are not usually available. It was established to: BioTradeStatus Sound, predictable, science-based regulations enable the delivery of innovation to the marketplace — and new agricultural innovations help grow more food in a sustainable way.

The members elected to the Bureau were:. This article discusses how the international debate over genetically modified (GM) food has intersected with the development of two global trade frameworks: the World Trade Organization (WTO) agreements and the UN Convention on Biological Diversity's (CBD's) Cartagena Protocol on Biosafety.

Today, the Convention is the main international instrument for addressing biodiversity issues. It provides a comprehensive and holistic approach to the conservation of biological diversity, the sustainable use of natural Cartagena Protocol on Biosafety Cartagena Protocol on Biosafety Proto/ang 11/13/ PM Page 4.

1 Cartagena Protocol on Biosafety to the Convention on Biological Diversity, Jan. 29,39 I.L.M [hereinafter Biosafety Protocol].

Timely Regulations Enable Innovations that Bring Economic and Social Benefits

I will use the terms “Biosafety Protocol” and “the Protocol” interchangeably throughout this article to refer to the Cartagena Protocol on Biosafety.

Today, the Convention is the main international instrument for addressing biodiversity issues. It provides a comprehensive and holistic approach to the conservation of biological diversity, the sustainable use of natural Cartagena Protocol on Biosafety Cartagena Protocol on Biosafety Proto/ang 11/13/ PM Page 4.

Pocket K No. 8: Cartagena Protocol on Biosafety

The Cartagena Protocol on Biosafety. The Cartagena Protocol on Biosafety to the Convention on Biological Diversity is an international agreement which aims to ensure the safe handling, transport and use of living modified organisms (LMOs) resulting from modern biotechnology that may have adverse effects on biological diversity, taking.

Apart from recommending a protocol on biosafety, the majority of Panel IV recommended the establishment of an Advance Informed Agreement (AIA) procedure covering all international transfers of genetically engineered organisms destined to be released or to be used in large scale production in the country of import.

A report on international biosafety protocol
Rated 3/5 based on 14 review
International Agreements: The WTO and the Biosafety Protocol